Brand Institute: Brand Institute Partners with Lexicon Pharmaceuticals on the Brand Name Development for FDA-Approved INPEFA (sotagliflozin)

Brand Institute is proud to announce its work with Lexicon Pharmaceuticals, Inc. in developing the brand name INPEFA (sotagliflozin), which was approved by the FDA on May 26, 2023.